Crinetics (CRNX) Fundamental Analysis: Revenue, Earnings & Valuation

2.88 / 10

Underperform

Fundamental rating is Underperform. Key strengths are low current‑liabilities‑to‑total‑liabilities (63%) and solid interest coverage (35×). However, revenue growth metrics are extreme and negative, and cost‑of‑sales ratio is high, indicating challenging earnings prospects.

Analysis Checks(7/10)

Revenue-MV

Value-4.38

Score1/3

Weight19.85%

1M Return4.09%

Total operating revenue (YoY growth rate %)

Value640.71

Score1/3

Weight-1.57%

1M Return-0.38%

Inventory turnover ratio

Value1.06

Score2/3

Weight-4.56%

1M Return-1.18%

Current liabilities / Total liabilities (%)

Value63.40

Score2/3

Weight1.54%

1M Return0.36%

PB-ROE

Value2.78

Score2/3

Weight37.28%

1M Return7.29%

Long-term debt to working capital ratio (%)

Value0.05

Score2/3

Weight-1.41%

1M Return-0.35%

Interest coverage ratio (EBIT / Interest expense) (%)

Value35.11

Score2/3

Weight-4.63%

1M Return-1.17%

Operating revenue (YoY growth rate %)

Value640.71

Score1/3

Weight-1.23%

1M Return-0.30%

Cost of sales ratio (%)

Value13.98

Score2/3

Weight-4.38%

1M Return-1.13%

Asset-MV

Value-0.55

Score2/3

Weight59.11%

1M Return11.12%

Is CRNX undervalued or overvalued?

CRNX scores 2.88/10 on fundamentals and holds a Premium valuation at present. Backed by its -40.17% ROE, -6046.22% net margin, -7.58 P/E ratio, 3.55 P/B ratio, and -34.15% earnings growth, these metrics solidify its Underperform investment rating.